Main Navigation

Mercia
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us

Audience

|

Change

  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub

Tagomics raises £6.7m to improve disease diagnosis

MEIF - Proof of Concept | 22nd February, 2024
Tagomics raises £6.7m to improve disease diagnosis
MEIF - Proof of Concept | 21st February, 2024
Spin-out raises £7.5m for novel treatment for blocked arteries
Mercia EIS Funds | 20th February, 2024
Webinar | Reducing your clients income tax with Mercia’s KI EIS fund
Direct Investments | 20th February, 2024
MIP Discovery raises £7m to drive commercialisation in cell and gene therapy
NPIF Debt | 19th February, 2024
From skins to sporrans – leather firm set to target new markets
North East Venture Fund | 15th February, 2024
Biotech firm raises £2.3m for lab models that help avoid animal testing
NPIF Debt | 13th February, 2024
Metrology firm secures funding to launch new demo centre
North East Venture Fund | 9th February, 2024
Spin-out raises £1.4m for lung test to aid early diagnosis of asthma
Mercia EIS Funds | 7th February, 2024
Invizius treats first patients with lead dialysis product H-Guard®
Mercia EIS Funds | 6th February, 2024
Webinar | How to manage CGT with Mercia KI EIS fund
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 135
Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept

© 2026 Mercia Asset Management

  • Contact us
  • Privacy policy
  • Terms and conditions
  • Modern Slavery Statement
  • Diversity, Equity & Inclusion Policy
  • Sustainability

Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept